Elizabeth Hyjek

Cornell University — United States

Medicine · Health Sciences

33h-index5.0kcitations143works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(32), Immune Cell Function and Interaction(27), Immune cells in cancer(17), Myeloproliferative Neoplasms: Diagnosis and Treatment(17), Chronic Myeloid Leukemia Treatments(16)

Publications143 total

Editorial Expression of Concern: Transformation of primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus
Nature·2025Open Access
<i>KRAS</i> may facilitate transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features
American Journal of Clinical Pathology·2025
CD5-positive B-cell acute lymphoblastic leukemia/lymphoma with MEF2D::BCL9 mimicking aggressive mature B-cell lymphoma: a case report of a newly described entity and potential diagnostic pitfall
Journal of Hematopathology·2025
Supplementary Table S8 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Data from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Table S10 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Data from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Figures S5-S9 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Figures S1-S4 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Figures S5-S9 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Table S8 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Table S10 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Table S1-16 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Figures S1-S4 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Supplementary Table S1-16 from Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
2024Open Access
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis
Blood Cancer Discovery·2024· 6 citedOpen Access
Review and Updates on Systemic Mastocytosis and Related Entities
Cancers·2023· 18 citedOpen Access
Data from Noncanonical Regulation of the Hedgehog Mediator &lt;i&gt;GLI1&lt;/i&gt; by c-MYC in Burkitt Lymphoma
2023Open Access
Supplementary Figure 1 from Noncanonical Regulation of the Hedgehog Mediator &lt;i&gt;GLI1&lt;/i&gt; by c-MYC in Burkitt Lymphoma
2023Open Access
Data from Noncanonical Regulation of the Hedgehog Mediator &lt;i&gt;GLI1&lt;/i&gt; by c-MYC in Burkitt Lymphoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Amy Chadburn(9), Ethel Cesarman(7), Danuta Kozbor(6), Daniel M. Knowles(5), Thomas Krausz(4), James W. Vardiman(4), Aliya N. Husain(3), Anna Porwit(3), Harold W. Lischner(3), Jacek Bartkowiak(3), John Anastasi(3), Michael J. Thirman(3), Can Gong(2), April Chiu(2), Dorothy A. Sipkins(2), Ainhoa Arina(2), Hans Schreiber(2), Ashraf Badros(2), Ning Ma(2), Alexander M. Lesokhin(2)